ES2255977T3 - Utilizacion de un compuesto farmaceutico que contiene desoxipeganina para el tratamiento de la dependencia a la nicotina. - Google Patents

Utilizacion de un compuesto farmaceutico que contiene desoxipeganina para el tratamiento de la dependencia a la nicotina.

Info

Publication number
ES2255977T3
ES2255977T3 ES00905035T ES00905035T ES2255977T3 ES 2255977 T3 ES2255977 T3 ES 2255977T3 ES 00905035 T ES00905035 T ES 00905035T ES 00905035 T ES00905035 T ES 00905035T ES 2255977 T3 ES2255977 T3 ES 2255977T3
Authority
ES
Spain
Prior art keywords
deoxipeganin
treatment
nicotine
compound containing
dependence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00905035T
Other languages
English (en)
Spanish (es)
Inventor
Bodo Asmussen
Thomas Hille
Hans-Rainer Hoffmann
Klaus Opitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HF Arzneimittelforschung GmbH and Co KG
Original Assignee
HF Arzneimittelforschung GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HF Arzneimittelforschung GmbH and Co KG filed Critical HF Arzneimittelforschung GmbH and Co KG
Application granted granted Critical
Publication of ES2255977T3 publication Critical patent/ES2255977T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES00905035T 1999-02-19 2000-02-08 Utilizacion de un compuesto farmaceutico que contiene desoxipeganina para el tratamiento de la dependencia a la nicotina. Expired - Lifetime ES2255977T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19906979 1999-02-19
DE19906979A DE19906979B4 (de) 1999-02-19 1999-02-19 Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

Publications (1)

Publication Number Publication Date
ES2255977T3 true ES2255977T3 (es) 2006-07-16

Family

ID=7898025

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00905035T Expired - Lifetime ES2255977T3 (es) 1999-02-19 2000-02-08 Utilizacion de un compuesto farmaceutico que contiene desoxipeganina para el tratamiento de la dependencia a la nicotina.

Country Status (12)

Country Link
US (1) US6548510B1 (OSRAM)
EP (1) EP1150681B1 (OSRAM)
JP (1) JP4287596B2 (OSRAM)
KR (1) KR100681631B1 (OSRAM)
AR (1) AR022621A1 (OSRAM)
AT (1) ATE314850T1 (OSRAM)
AU (1) AU2670600A (OSRAM)
DE (2) DE19906979B4 (OSRAM)
DK (1) DK1150681T3 (OSRAM)
ES (1) ES2255977T3 (OSRAM)
PT (1) PT1150681E (OSRAM)
WO (1) WO2000048445A2 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
DE10304141B4 (de) 2003-02-03 2006-03-09 Hf Arzneimittelforschung Gmbh Verfahren zur Herstellung von Chinazolin-Alkaloiden
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
WO2008007163A1 (en) * 2006-07-11 2008-01-17 Adnan Jathlan Al-Rehaily Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
DK2552245T3 (en) 2010-03-26 2019-01-07 Philip Morris Products Sa INHIBITION OF SENSORY IRRITATION UNDER CONSUMPTION OF NON-SMOKABLE TOBACCO PRODUCTS
US10335378B2 (en) 2013-03-15 2019-07-02 Altria Client Services Llc Inhibition of central nervous system effects from smoking and sensory effects from smoking
CN104382964B (zh) * 2014-10-27 2017-07-28 上海中医药大学 一种由骆驼蓬草制备骆驼蓬草总生物碱提取物和骆驼蓬草总黄酮提取物的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3760805A (en) 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
US3987790A (en) 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4137300A (en) 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
DE3629304A1 (de) 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3843239C1 (OSRAM) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus

Also Published As

Publication number Publication date
PT1150681E (pt) 2006-05-31
EP1150681B1 (de) 2006-01-04
KR20010102240A (ko) 2001-11-15
DE19906979B4 (de) 2004-07-08
DK1150681T3 (da) 2006-05-22
WO2000048445A3 (de) 2001-04-26
AU2670600A (en) 2000-09-04
EP1150681A2 (de) 2001-11-07
JP2002537232A (ja) 2002-11-05
KR100681631B1 (ko) 2007-02-09
DE19906979A1 (de) 2000-08-31
DE50012014D1 (de) 2006-03-30
AR022621A1 (es) 2002-09-04
WO2000048445A2 (de) 2000-08-24
JP4287596B2 (ja) 2009-07-01
US6548510B1 (en) 2003-04-15
ATE314850T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
ES2443847T3 (es) Uso de betanecol para el tratamiento de xerostomía
KR101859486B1 (ko) 설하용 덱스메데토미딘 조성물과 그의 사용 방법
KR100301547B1 (ko) 니코틴의존증치료용약학조성물
KR100511730B1 (ko) 활성성분의 개선된 전달성을 갖는 조성물
ES2255977T3 (es) Utilizacion de un compuesto farmaceutico que contiene desoxipeganina para el tratamiento de la dependencia a la nicotina.
ES2255287T3 (es) Composiciones para el tratamiento de la leucemia linfocitica cronica.
MXPA02003312A (es) Composiciones que tienen estabilidad mejorada.
ES2216279T3 (es) Uso de misoprostol y/o acido de misoprostol para el tratamiento de la disfuncion erectil.
RU2255736C2 (ru) Фармацевтические композиции, содержащие золмитриптан
AU747975B2 (en) Oral liquid antidepressant solution
JP2015511213A (ja) 薬物送達技術
KR20010093256A (ko) 개선된 안정성을 갖는 조성물
US20150352038A1 (en) A dosage form for administering an active principle for accelerated sleep induction and/or for treating sleep disorders and/or for treating a central nervous system disorder
KR20010101476A (ko) 개선된 안정성을 갖는 조성물
US20100233244A1 (en) Smoking Withdrawal Combination Wafer
ES2248047T3 (es) Compuesto farmaceutico que contiene desoxipeganina para el tratamiento del alcoholismo.
EP0315332A1 (en) Antitussive liquid compositions containing phenol
ES2340164T3 (es) Formulas orales de galantamina y sus aplicaciones.
EP2900213B1 (en) Improvements in or relating to oromucosal apomorphine compositions
CN101983052B (zh) 一种通过跨口腔粘膜途径进行曲坦类药物给药的药物制剂
EP1203585B1 (en) Anti-ischemic agent
EP3967298A1 (en) Aerosol composition for oral use
HU226374B1 (en) Pharmaceutical combination of a bradykinin antagonist and an antiviral agent
AR020167A1 (es) Metodo para la prevencion del inicio del asma
ES2356563T3 (es) Administración transdérmica de meptazinol.